PN
Parul Nikunj Shah
About Parul Nikunj Shah
Data last updated:
Parul Nikunj Shah is a Director at Cadila Pharmaceuticals Limited (since 2023) and Director at Irm Enterprises Private Limited (since 2021). The companies operate in Pharma and Agriculture. The 2 current companies with reported revenue have a combined latest revenue of ₹4,021 Cr; the largest is Cadila Pharmaceuticals Limited at ₹3,869 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cadila Pharmaceuticals Limited U24231GJ1991PLC015132 | Director | 01 Dec 2023 | 1991 | ₹3,869 Cr (FY 2025) | Active |
 Irm Enterprises Private Limited U74110GJ2009PTC058116 | Director | 17 Sep 2021 | 2009 | ₹152 Cr (FY 2025) | Active |
Board colleagues of Parul Nikunj Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Girdhar Prem Balwani | 00328949 | Cadila Pharmaceuticals Limited | Director |
| Kamlesh Navaratnalal Shah | Cadila Pharmaceuticals Limited | Cfo | |
| Rajiv Indravadan Modi | 01394558 | Cadila Pharmaceuticals Limited , Irm Enterprises Private Limited | Managing Director |
| Rajiv Rajiv Modi | 10276899 | Cadila Pharmaceuticals Limited , Irm Enterprises Private Limited | Director |
| Ramesh Ratilal Choksi | 06636737 | Cadila Pharmaceuticals Limited , Irm Enterprises Private Limited | Whole-Time Director |
| Renuka Anjanikumar Upadhyay | Cadila Pharmaceuticals Limited | Company Secretary | |
| Subir Kumar Das | 02237356 | Cadila Pharmaceuticals Limited , Irm Enterprises Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Parul Nikunj Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Parul Nikunj Shah
Parul Nikunj Shah currently holds 2 directorships: Cadila Pharmaceuticals Limited (Director, since 01 Dec 2023, revenue ₹3,869 Cr (FY 2025)); Irm Enterprises Private Limited (Director, since 17 Sep 2021, revenue ₹152 Cr (FY 2025)).
Parul Nikunj Shah was first appointed on 17 Sep 2021 as Director at Irm Enterprises Private Limited. The most recent appointment on record is 01 Dec 2023 at Cadila Pharmaceuticals Limited.
The 2 current companies of Parul Nikunj Shah that report revenue have a combined latest revenue of ₹4,021 Cr: Cadila Pharmaceuticals Limited ₹3,869 Cr (FY 2025); Irm Enterprises Private Limited ₹152 Cr (FY 2025).
The current boards of Parul Nikunj Shah's companies include Girdhar Prem Balwani (Cadila Pharmaceuticals Limited), Kamlesh Navaratnalal Shah (Cadila Pharmaceuticals Limited), Rajiv Indravadan Modi (Cadila Pharmaceuticals Limited), Rajiv Rajiv Modi (Cadila Pharmaceuticals Limited), Ramesh Ratilal Choksi (Cadila Pharmaceuticals Limited), Renuka Anjanikumar Upadhyay (Cadila Pharmaceuticals Limited), among others.